Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Traws Pharma, Inc. (TRAW)
Company Research
Source: Seeking Alpha
Iain Dukes - CEO, Secretary & Director Charles Parker - Chief Financial Officer Conference Call Participants John Fraunces - Lifesci Advisors, LLC Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Traws [Technical Difficulty]. [Operator Instructions] As a reminder, this call is recorded. I would now like to turn the call over to John Fraunces, LifeSci Advisors. John Fraunces Lifesci Advisors, LLC Thank you, operator, and welcome, everyone, to Traws Pharma's Full Year 2025 Financial Results and Business Update Conference Call. This afternoon, Traws issued a press release reporting its 2025 financial results and provided a business update. If you have not yet seen this press release, it is available in the Investor Relations section of the company's website. Following my introduction, we will hear from Traw's Chief Executive Officer, Dr. Iain Dukes; and Chief Financial Officer, Charles Parker. Before we begin, I would like to
Show less
Read more
Impact Snapshot
Event Time:
TRAW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRAW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRAW alerts
High impacting Traws Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
TRAW
News
- Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turnaround Year with Significant ... [Yahoo! Finance]Yahoo! Finance
- Traws Pharma Announces Up to $60 Million Private Placement Financing [Yahoo! Finance]Yahoo! Finance
- Traws Pharma Reports Full Year 2025 Results and Provides Business HighlightsGlobeNewswire
- Traws Pharma Announces Up to $60 Million Private Placement FinancingGlobeNewswire
- Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal InfluenzaGlobeNewswire
TRAW
Analyst Actions
- 1/30/26 - LADENBURG
TRAW
Sec Filings
- 4/15/26 - Form 10-K
- 4/15/26 - Form 8-K
- 4/15/26 - Form 8-K
- TRAW's page on the SEC website